The Cooper Companies Inc (COO)
93.75
+1.35
(+1.46%)
USD |
NASDAQ |
May 07, 12:57
Cooper SG&A Expense (Quarterly): 380.90M for Jan. 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
January 31, 2024 | 380.90M |
October 31, 2023 | 387.60M |
July 31, 2023 | 375.20M |
April 30, 2023 | 407.50M |
January 31, 2023 | 330.90M |
October 31, 2022 | 358.00M |
July 31, 2022 | 342.70M |
April 30, 2022 | 322.40M |
January 31, 2022 | 319.10M |
October 31, 2021 | 311.60M |
July 31, 2021 | 352.50M |
April 30, 2021 | 285.80M |
January 31, 2021 | 261.20M |
October 31, 2020 | 264.20M |
July 31, 2020 | 232.80M |
April 30, 2020 | 237.20M |
January 31, 2020 | 258.30M |
October 31, 2019 | 249.60M |
July 31, 2019 | 249.80M |
April 30, 2019 | 246.80M |
January 31, 2019 | 250.00M |
October 31, 2018 | 248.60M |
July 31, 2018 | 251.00M |
April 30, 2018 | 247.90M |
January 31, 2018 | 225.90M |
Date | Value |
---|---|
October 31, 2017 | 208.50M |
July 31, 2017 | 208.70M |
April 30, 2017 | 193.30M |
January 31, 2017 | 188.60M |
October 31, 2016 | 189.10M |
July 31, 2016 | 182.40M |
April 30, 2016 | 177.70M |
January 31, 2016 | 173.60M |
October 31, 2015 | 179.60M |
July 31, 2015 | 191.78M |
April 30, 2015 | 167.58M |
January 31, 2015 | 173.54M |
October 31, 2014 | 208.02M |
July 31, 2014 | 161.20M |
April 30, 2014 | 155.80M |
January 31, 2014 | 158.09M |
October 31, 2013 | 157.25M |
July 31, 2013 | 152.14M |
April 30, 2013 | 150.69M |
January 31, 2013 | 136.57M |
October 31, 2012 | 147.36M |
July 31, 2012 | 143.83M |
April 30, 2012 | 136.96M |
January 31, 2012 | 131.75M |
October 31, 2011 | 139.68M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
232.80M
Minimum
Jul 2020
407.50M
Maximum
Apr 2023
311.96M
Average
319.10M
Median
Jan 2022
SG&A Expense (Quarterly) Benchmarks
Integer Holdings Corp | 46.93M |
Anika Therapeutics Inc | 20.34M |
Staar Surgical Co | 39.45M |
OrthoPediatrics Corp | 32.03M |
NexGel Inc | 1.22M |